|
Medinol was established in 1992 by Dr. Judith Richter and Dr. Jacob (Kobi) Richter. It was at that time that the two hallmarks of Medinol were first introduced: our ingenious stent design and our unique manufacturing technology.
Medinol's 1st generation NIR® stent revolutionized the interventional cardiology industry with its flexible closed cell design. This design breakthrough has inspired the stent industry and has been long accepted by many peer companies and manufacturers.
Medinol's 2nd generation stent, the NIR® Conformer, set new standards in the cardiology industry with the introduction of various configurations of the stent and the delivery system, including the NIRoyal (made of gold).
Medinol's 3rd generation stent, the NIRflex®, incorporates multifaceted improvements in design, material and manufacturing technology supplying additional flexibility and enhanced conformability to the vessel’s shape, while maintaining its trademark scaffolding capabilities.
The NIRflex® design serves as a platform for Medinol’s 4th generation stents which are made of Nitinol and Cobalt Chromium. These stents maximize the combined potential of the NIRflex® design and the use of advanced materials.
Today Medinol’s cardiology stents are distributed by Cordis (a Johnson & Johnson company).
|
|
